User login
Recent News About Rosetta Biosoftware
Rosetta Biosoftware Announces the Rosetta Syllego System Version 2.0
New system places translational medicine within researchers' grasp
Waters and Rosetta Biosoftware Achieve Collaborative Milestone
Advancing proteomics research with secure protein identifications
The Rosetta Resolver System Supports Affymetrix® GeneChip® Gene 1.0 ST Arrays
SEATTLE, Wash., March 12, 2008
Clinical Data, Inc Develops microRNA Analysis Capabilities with Rosetta Biosoftware
Cogenics Division of Clinical Data Contributes microRNA Analysis Expertise to Rosetta Resolver System
Rosetta Biosoftware's Rosetta Syllego System Achieves GeneChip-compatible™ Status with Affymetrix GeneChip® Microarray Platform
The Rosetta Syllego System version 1.0 will be showcased a the 57th annual meeting of the American Society for Human Genetics conference in San Diego, Calif., October 23-27.
FDA Utilizes The Rosetta Syllego™ System to Support Management of Genome-Wide Association Data Submitted Through VXDS Program
October 2, 2007 - Rosetta Biosoftware today announced that the U.S. Food and Drug Administration (FDA) will utilize the Rosetta Syllego™ system to meet its immediate need for a software solution to manage and analyze genotyping data used in genome-wide association (GWA) studies. Organizations are now beginning to submit genotyping data from GWA studies to the FDA through its Voluntary eXploratory Data Submission (VXDS) program.
Waters Corporation and Rosetta Biosoftware Collaborate to Advance the Analysis of Complex Biological Mixtures
Focus is on Comprehensive Mass Spectrometry (MS) Data Interpretation
The Critical Path Institute Adopts the Rosetta Resolver® System for the Predictive Safety Testing Consortium
SEATTLE, Wash., and TUCSON, Ariz., March 19, 2007– Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path’s Predictive Safety Testing Consortium. The Consortium brings together major pharmaceutical companies to work in collaboration with C-Path and the U.S.
Rosetta Biosoftware Introduces the Rosetta Resolver® Gene Expression Data Analysis System Version 7.0
SEATTLE, Wash., March 5, 2007 – Rosetta Biosoftware today introduced the Rosetta Resolver® gene expression data analysis system 7.0, with capabilities to promote standardized data storage and exchange.
Rosetta Biosoftware Licenses Rosetta Resolver® Gene Expression Data Analysis System to the University of California, Los Angeles
SEATTLE, Wash. and LOS ANGELES, Calif., February 26, 2007 – Rosetta Biosoftware announced today that the University of California, Los Angeles (UCLA) licensed the Rosetta Resolver® system to support research at UCLA's Jonsson Comprehensive Cancer Center (JCCC).
Ben-Gurion University of the Negev Deploys Rosetta Biosoftware Systems for a Pilot Study in Bioinformatics
SEATTLE, Washington, U.S.A.
Oji Paper Co., Ltd. Licenses the Rosetta Resolver® Gene Expression Data Analysis System from Rosetta Biosoftware
SEATTLE, Washington, U.S.A and TOKYO, Japan, January 16, 2007– Rosetta Biosoftware announced today that Oji Paper Co., Ltd.
Eisai Co., Ltd. Licenses the Elucidator® Protein Expression Data Analysis System from Rosetta Biosoftware
SEATTLE, Washington, U.S.A and TOKYO Japan – 2 January, 2007 – Rosetta Biosoftware announced today that Eisai Co., Ltd. licensed the Elucidator® system for differential protein expression analysis and biomarker discovery.
H. Lee Moffitt Cancer Center & Research Institute Licenses Rosetta Resolver® Gene Expression Analysis System
SEATTLE, Wash., and TAMPA, Fla., December 4, 2006 – Rosetta Biosoftware announced today that the H. Lee Moffitt Cancer Center & Research Institute licensed the Rosetta Resolver® system.
CXR Biosciences Ltd. Licenses the Rosetta Resolver® Gene Expression Data Analysis System from Rosetta Biosoftware
SEATTLE, Washington, U.S.A. and Dundee, Scotland, U.K., 20 November, 2006 – Rosetta Biosoftware announced today that CXR Biosciences Ltd.
Rosetta Biosoftware Announces the Formation of a Scientific Advisory Board to Advance Future Development and Scientific Research
SEATTLE, Wash., August 23, 2006– Rosetta Biosoftware announced today the formation of a Scientific Advisory Board to provide guidance for the future development and commercialization of products in the area of proteomics. The Scientific Advisory Board comprises the following individuals: Dr.
National Oceanic and Atmospheric Administration Licenses the Rosetta Resolver Gene Expression Data Analysis System
SEATTLE, Wash., and WASHINGTON, D.C., August 1, 2006– Rosetta Biosoftware announced today that the National Oceanic and Atmospheric Administration (NOAA) has purchased a license for its Rosetta Resolver® system to cond
Rosetta Biosoftware Licenses the Rosetta Resolver Expression Data Analysis System to University of Nebraska-Lincoln
SEATTLE , Wash. , July 1 7, 2006 – Rosetta Biosoftware announced today that University of Nebraska-Lincoln (UNL) licensed the Rosetta Resolver® system to study gene regulation networks at the UNL Center for Biotechnology.
Rosetta Biosoftware Leverages Borland ALM Products to Help Customers Reduce Time and Cost of Drug Development
New system developed with Borland tools used by the U.S. Food and Drug Administration’s Center for Drug Evaluation, pharmaceutical companies, premier academic institutions and service providers
 |
+1 206 926 1200 |
 |
info@rosettabio.com |
 |
401 Terry Avenue N, Seattle, WA 98109, USA |